These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16371926)

  • 1. Rituximab therapy for de novo mixed cryoglobulinemia in renal transplant patients.
    Basse G; Ribes D; Kamar N; Mehrenberger M; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
    Transplantation; 2005 Dec; 80(11):1560-4. PubMed ID: 16371926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab therapy for mixed cryoglobulinemia in seven renal transplant patients.
    Basse G; Ribes D; Kamar N; Mehrenberger M; Sallusto F; Esposito L; Guitard J; Lavayssière L; Oksman F; Durand D; Rostaing L
    Transplant Proc; 2006 Sep; 38(7):2308-10. PubMed ID: 16980074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab as a therapeutic tool in severe mixed cryoglobulinemia.
    Roccatello D; Baldovino S; Rossi D; Giachino O; Mansouri M; Naretto C; Di Simone D; Francica S; Cavallo R; Alpa M; Napoli F; Sena LM
    Clin Rev Allergy Immunol; 2008 Feb; 34(1):111-7. PubMed ID: 18270864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should rituximab be the rescue therapy for refractory mixed cryoglobulinemia associated with hepatitis C?
    Ahmed MS; Wong CF
    J Nephrol; 2007; 20(3):350-6. PubMed ID: 17557269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD20 monoclonal antibody (rituximab) treatment for hepatitis C-negative therapy-resistant essential mixed cryoglobulinemia with renal and cardiac failure.
    Ghijsels E; Lerut E; Vanrenterghem Y; Kuypers D
    Am J Kidney Dis; 2004 May; 43(5):e34-8. PubMed ID: 15112197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in liver cirrhosis after treatment of HCV-related mixed cryoglobulinemia with rituximab.
    Petrarca A; Rigacci L; Monti M; Giannini C; Bernardi F; Caini P; Colagrande S; Bosi A; Laffi G; Zignego AL
    Dig Liver Dis; 2007 Sep; 39 Suppl 1():S129-33. PubMed ID: 17936214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kidney involvement in mixed cryoglobulinemia: which treatment?].
    Cacoub P
    Presse Med; 2012 Mar; 41(3 Pt 1):254-9. PubMed ID: 22192935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab may form a complex with IgMkappa mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis.
    Sène D; Ghillani-Dalbin P; Amoura Z; Musset L; Cacoub P
    Arthritis Rheum; 2009 Dec; 60(12):3848-55. PubMed ID: 19950292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of anti-CD20 monoclonal antibody treatment of cryoglobulinaemic glomerulonephritis.
    Roccatello D; Baldovino S; Rossi D; Mansouri M; Naretto C; Gennaro M; Cavallo R; Alpa M; Costanzo P; Giachino O; Mazzucco G; Sena LM
    Nephrol Dial Transplant; 2004 Dec; 19(12):3054-61. PubMed ID: 15494358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus-related cryoglobulinemia and glomerulonephritis: pathogenesis and therapeutic strategies.
    Garini G; Allegri L; Vaglio A; Buzio C
    Ann Ital Med Int; 2005; 20(2):71-80. PubMed ID: 16052839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Life-threatening infections following rituximab therapy in renal transplant patients with mixed cryoglobulinemia.
    Basse G; Ribes D; Kamar N; Esposito L; Rostaing L
    Clin Nephrol; 2006 Nov; 66(5):395-6. PubMed ID: 17140171
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus infection and rituximab therapy after renal transplantation.
    Fabrizi F; Martin P; Elli A; Montagnino G; Banfi G; Passerini P; Campise MR; Tarantino A; Ponticelli C
    Int J Artif Organs; 2007 May; 30(5):445-9. PubMed ID: 17551909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential mixed cryoglobulinemia type III with leukocytoclastic vasculitis: remission by rituximab.
    Baerlecken NT; Schmidt RE
    Clin Rheumatol; 2013 Mar; 32 Suppl 1():S19-20. PubMed ID: 20213127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of rituximab in type II mixed cryoglobulinemia.
    Zaja F; De Vita S; Mazzaro C; Sacco S; Damiani D; De Marchi G; Michelutti A; Baccarani M; Fanin R; Ferraccioli G
    Blood; 2003 May; 101(10):3827-34. PubMed ID: 12560225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD20 monoclonal antibody (rituximab) treatment for cryoglobulinemic vasculitis: where do we stand?
    Cacoub P; Delluc A; Saadoun D; Landau DA; Sene D
    Ann Rheum Dis; 2008 Mar; 67(3):283-7. PubMed ID: 17644544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatitis C-virus-related glomerulonephritis.
    Kamar N; Rostaing L; Alric L
    Kidney Int; 2006 Feb; 69(3):436-9. PubMed ID: 16514428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab in mixed cryoglobulinemia: increased experience and perspectives.
    De Vita S; Quartuccio L; Fabris M
    Dig Liver Dis; 2007 Sep; 39 Suppl 1():S122-8. PubMed ID: 17936213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized, prospective trial of rituximab for acute rejection in pediatric renal transplantation.
    Zarkhin V; Li L; Kambham N; Sigdel T; Salvatierra O; Sarwal MM
    Am J Transplant; 2008 Dec; 8(12):2607-17. PubMed ID: 18808404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon alpha with an anti-CD20.
    Sansonno D; De Re V; Lauletta G; Tucci FA; Boiocchi M; Dammacco F
    Blood; 2003 May; 101(10):3818-26. PubMed ID: 12506023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal failure secondary to severe type I cryoglobulinemia following rituximab therapy for Waldenström's macroglobulinemia.
    Shaikh A; Habermann TM; Fidler ME; Kumar S; Leung N
    Clin Exp Nephrol; 2008 Aug; 12(4):292-295. PubMed ID: 18288560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.